Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Share News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.25
Bid: 12.50
Ask: 14.00
Change: 0.00 (0.00%)
Spread: 1.50 (12.00%)
Open: 13.25
High: 13.50
Low: 13.00
Prev. Close: 13.25
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Belluscura agrees GBP5.8 million deal to buy TMT Acquisition

Tue, 31st Oct 2023 17:47

(Alliance News) - Belluscura PLC on Tuesday said it had agreed to buy TMT Acquisition PLC in all-share deal valuing the latter at GBP5.8 million.

Under the terms of the offer, TMT shareholders will receive three Belluscura shares in exchange for every four held in TMT.

Belluscura said based on its closing share price of 28.0 pence on Tuesday, this would value each TMT share at 21.0 pence, a premium of 24% to TMT's closing share price on October 2.

Shares in Belluscura closed down 0.4% at 27.89 pence each in London on Tuesday. Shares in TMT Acquisition closed down 7.7% at 16.15 pence.

On October 3, Belluscura and TMT said they had struck a deal which valued TMT at GBP6.0 million. After completing due diligence, the terms of the agreement were then revised in a statement released last Wednesday. The altered structure was reflected in the terms announced today.

Adam Reynolds, chair of Belluscura, said: "I regard the all share offer for TMT Acquisition as highly compelling as, in combination with Belluscura's recent fundraising, it provides the funding for Belluscura to execute on its burgeoning sales pipeline and meet planned growth through to it becoming cash flow positive, creating considerable value for all stakeholders of both TMT Acquisition and Belluscura."

Paul Tuson, the independent director of TMT Acquisition, said: "I am delighted to have agreed terms with Belluscura which result in TMT Acquisition shareholders receiving a premium to the cash value per TMT Acquisition."

"While this is not without its risks, it offers potential for significant upside," he added.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Jun 2021 17:25

TRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue

TRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue

Read more
23 Jun 2021 07:55

Belluscura inks first US distribution agreement

(Sharecast News) - Medical device developer Belluscura has signed its first US distribution agreement for the firm's X-PLO2R portable oxygen concentrator portfolio.

Read more
15 Jun 2021 19:33

EXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years

EXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years

Read more
28 May 2021 10:08

AIM debutant Belluscura plots growth in respiratory devices market

AIM debutant Belluscura plots growth in respiratory devices market

Read more
28 May 2021 08:58

LONDON MARKET OPEN: European equities take heart from US budget plan

LONDON MARKET OPEN: European equities take heart from US budget plan

Read more
28 May 2021 07:43

LONDON MARKET PRE-OPEN: Astra drug backed; cocktails click at AG Barr

LONDON MARKET PRE-OPEN: Astra drug backed; cocktails click at AG Barr

Read more
29 Mar 2018 08:07

EUROPE RESEARCH ROUNDUP-BASF SE, SIG, Ted Baker

March 29 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BASF SE, SIG Plc and Ted Baker Plc, on Thursday. HIGHLIGHTS * BASF SE : to

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.